Markets:

Overview

News

Currencies

International

Treasuries

Zura Bio Limited - Class A Ordinary shares (NQ:ZURA)

5.080 -0.080 (-1.55%)

Streaming Delayed Price Updated: 10:09 AM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zura Bio Limited - Class A Ordinary shares

< Previous 1 2 3 4 Next >

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants

August 12, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

August 09, 2024

From Zura Bio Limited

Via Business Wire

ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024 ↗

May 09, 2024

ZURA stock results show that Zura Bio beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors

August 01, 2024

From Sagimet Biosciences Inc.

Via GlobeNewswire

3 Undervalued Biotech Stocks With Breakout Potential ↗

July 19, 2024

Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements

Via InvestorPlace

Zura Bio Commences Warrant Exchange Offer and Consent Solicitation

July 12, 2024

From Zura Bio Limited

Via Business Wire

The 3 Most Undervalued Biotech Stocks to Buy in July 2024 ↗

July 12, 2024

There’s always a strong case for undervalued biotech stocks especially with newer innovation and demand for better treatment.

Via InvestorPlace

Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024

June 14, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology

June 06, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024

June 03, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio Announces Participation in June Investor Conferences

May 29, 2024

From Zura Bio Limited

Via Business Wire

3 Penny Stocks to Buy Now: May 2024 ↗

May 24, 2024

Penny stocks to buy carry a considerable amount of risk and extra sue dilligence is required before buying shares.

Via InvestorPlace

Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 09, 2024

From Zura Bio Limited

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 26, 2024

Via Benzinga

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

April 18, 2024

From Zura Bio

Via Business Wire

Zura Bio Announces Robert Lisicki as CEO and Director

April 08, 2024

From Zura Bio Limited

Via Business Wire

ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023 ↗

March 28, 2024

ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer

March 28, 2024

From Zura Bio Limited

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 22, 2024

Via Benzinga

Zura Bio Announces Participation at March Conferences

March 04, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio Announces Participation at February Investor Conferences

February 02, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO

January 08, 2024

From Zura Bio Limited

Via Business Wire

Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit

January 03, 2024

From Zura Bio Limited

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

December 04, 2023

From Zura Bio Limited

Via Business Wire

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

November 14, 2023

From Zura Bio Limited

Via Business Wire

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

November 13, 2023

From Zura Bio Limited

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗

October 10, 2023

Via Benzinga

Zura Bio Enters into Sponsored Research Agreement with Benaroya Research Institute

September 12, 2023

From Zura Bio Limited

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023 ↗

August 25, 2023

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.